| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/01/1999 | EP0938296A1 Method of treating alopecia |
| 09/01/1999 | EP0938295A1 An orally administrable, paste-like composition for veterinary use, a method for the preparation thereof, and the use of an oily vehicle for the manufacture of such composition |
| 09/01/1999 | EP0938262A2 Nematicidal bacillus strain and metabolite and methods of use thereof |
| 09/01/1999 | EP0938258A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no) |
| 09/01/1999 | EP0862391A4 Retrievable bioartificial implants |
| 09/01/1999 | EP0854855A4 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions |
| 09/01/1999 | EP0723455A4 Methods of inhibiting phagocytosis |
| 09/01/1999 | EP0721348B1 Monoglyceride/lactate ester permeation enhancer |
| 09/01/1999 | EP0706382B1 Therapeutic preparation for inhalation |
| 09/01/1999 | EP0691842B1 Lidocaine aerosol anaesthetic |
| 09/01/1999 | EP0626862B1 Drug system comprising a gel matrix containing an immobilized drug |
| 09/01/1999 | EP0528971B1 Surgical implant and method incorporating chemotherapeutic agents |
| 09/01/1999 | CN1227503A Novel device for transdermal administering of trimegestone |
| 09/01/1999 | CN1227498A 医用粉末 Medical powder |
| 09/01/1999 | CN1227492A Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine |
| 09/01/1999 | CN1227490A Fat emulsion containing xanthine derivative |
| 09/01/1999 | CN1227484A Hydrolyzed cellulose granulations for pharmaceuticals |
| 09/01/1999 | CN1227125A Compound beta interferon lozenge and its preparing method |
| 09/01/1999 | CN1227124A Beta interferon lozenge and its preparing method |
| 09/01/1999 | CN1227116A Technology for producing comedo eliminating liquid |
| 09/01/1999 | CN1227113A Medicine bolus for herpatitis B made of black ant, grub and other herbs |
| 09/01/1999 | CN1227108A Method for preparing burn plaster |
| 09/01/1999 | CN1227104A External use Chinese drug powder and its preparing method and medicinal pad |
| 09/01/1999 | CN1227100A Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method |
| 09/01/1999 | CN1044861C Chinese drug injection for treatment of ischemic cerebrovascular disease |
| 09/01/1999 | CN1044859C Hemorrhoid-eliminating lotion |
| 09/01/1999 | CN1044858C Body strong reinforcing kindery and pain stop ointment and preparing method |
| 08/31/1999 | US5945514 Mannose binding lectin bonded through hydrophylic high molecular weight chain to hydrophobic molecular weight chain; aerosols, creams, lotions for prophylactic use against human immunodeficiency viruses and others |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945426 Derivatives of pyrimidine for treating acute cerebrovascular disorders |
| 08/31/1999 | US5945405 Crystal form O of clarithromycin |
| 08/31/1999 | US5945402 Human relaxin formulation |
| 08/31/1999 | US5945400 Nucleic acid-containing composition, preparation and use thereof |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945272 Autoclavable mixture of subphysiological concentrations of potassium, magnesium, sodium, calcium and chloride ions; water soluble oncotic agents; carboxylic acids or salts; and blood clotting factors; free of biological buffers |
| 08/31/1999 | US5945129 Process for the production of an infusion or dialysis solution containing bicarbonate |
| 08/31/1999 | US5945128 Process to manufacture implants containing bioactive peptides |
| 08/31/1999 | US5945127 Storage-stable drug form |
| 08/31/1999 | US5945126 Forming a dispersed phase comprising a drug and a polymer, providing a continuous phase and continuously feeding dispersed phase and continuous phase according their phase feed rates to form emulsion, removing the solvent |
| 08/31/1999 | US5945125 Consists of a single homogenous mixture of a drug selected from nifedipine, diclofenac sodium, salicylic acid, theophylline anhydrous etc. and an excipient comprising polyethylene oxide and lubricant |
| 08/31/1999 | US5945124 Bactericide |
| 08/31/1999 | US5945123 Determining known pharacokinetic parameters of therapeutical substance, number of doses to be administered during 24 hours and determining time at which dose will be adminstered by considering both schedule and physiological anamolies |
| 08/31/1999 | US5945122 Liposomes containing a cisplatin compound |
| 08/31/1999 | US5945121 Liposome eye drops |
| 08/31/1999 | US5945120 Gelified microspheres, their method of preparation and their applications |
| 08/31/1999 | US5945119 A plastic strip having microporous material impregnated with cesium chloride and magnesium sulfate on both side as antiarthritic agent or treatment of other soft tissue injuries; antiinflammatory agents |
| 08/31/1999 | US5945115 Polymeric compositions useful as controlled release implants |
| 08/31/1999 | US5945100 Tumor delivery vehicles |
| 08/31/1999 | US5945085 Consists of sodium bicarbonate as primary ingredient, antiperspirant astringent salt, volatile silicon oil, carboxylate ester emollient, clay as hydrophobic suspending agent |
| 08/31/1999 | US5945033 Albumin, hemoglobin mixture; stability |
| 08/31/1999 | US5944740 Conductive device to be applied to skin and method of use thereof |
| 08/31/1999 | US5944012 Dry powder with permeation promoter |
| 08/31/1999 | CA2125282C Pharmaceutically applicable nanosol and process for preparing the same |
| 08/31/1999 | CA2118030C Drug for increasing the level of testosterone in the body |
| 08/31/1999 | CA2091776C Liposome extrusion process |
| 08/31/1999 | CA2007334C Anti-ulcer composition |
| 08/31/1999 | CA2006028C Cosmetic or pharmaceutical composition containing polymers or fatty bodies microspheres with at least one active ingredient |
| 08/27/1999 | CA2230801A1 Composition comprising micro-encapsulated iron |
| 08/26/1999 | WO1999042397A1 Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile |
| 08/26/1999 | WO1999042177A1 Radioactive stent |
| 08/26/1999 | WO1999042163A1 Thin film radiation source |
| 08/26/1999 | WO1999042135A1 Micronutrient-dispensing device and method |
| 08/26/1999 | WO1999042134A2 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders |
| 08/26/1999 | WO1999042131A1 Skin care compositions |
| 08/26/1999 | WO1999042125A1 Pharmaceutical formulation of a didemnin compound |
| 08/26/1999 | WO1999042124A1 Liquid crystal forms of cyclosporin |
| 08/26/1999 | WO1999042112A1 Process for preparing solid preparation by using colloid of platinum and palladium as main raw material and use thereof |
| 08/26/1999 | WO1999042110A1 Regulation of estrus and ovulation in gilts |
| 08/26/1999 | WO1999042095A1 Pharmaceutical combinations containing tramadol |
| 08/26/1999 | WO1999042088A2 Method for the treatment of diseases or disorders of the inner ear |
| 08/26/1999 | WO1999042087A2 Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content |
| 08/26/1999 | WO1999042086A1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 08/26/1999 | WO1999042085A1 Erythropoietin liposomal dispersion |
| 08/26/1999 | WO1999042083A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 08/26/1999 | WO1999042039A1 Implantable therapeutic device and method |
| 08/26/1999 | WO1999031060A3 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 08/26/1999 | WO1999027954A3 Mixed lipopeptide micelles for inducing an immune response |
| 08/26/1999 | DE19808634A1 Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties |
| 08/26/1999 | DE19807535A1 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying |
| 08/26/1999 | DE19749897C1 Composite especially for tablet production |
| 08/26/1999 | CA2321102A1 Regulation of estrus and ovulation in gilts |
| 08/26/1999 | CA2320986A1 Thin film radiation source |
| 08/26/1999 | CA2320982A1 Radioactive stent |
| 08/26/1999 | CA2320060A1 Skin care compositions |
| 08/26/1999 | CA2263703A1 A process for producing enteric coated pancreatin granules |
| 08/25/1999 | EP0937755A1 Precipitated silica granules |
| 08/25/1999 | EP0937463A1 Skin care compositions |
| 08/25/1999 | EP0937456A1 Erythropoietin liposomal dispersion |
| 08/25/1999 | EP0937247A1 A dissolution test method for solid steroidal pharmaceutical formulations |
| 08/25/1999 | EP0936916A1 Cosmetic compositions |
| 08/25/1999 | EP0936913A1 Oral pharmaceutical preparation containing ibandronat |
| 08/25/1999 | EP0936905A1 Immediate wettability water soluble film or water soluble layer for oral application |
| 08/25/1999 | EP0936904A1 Device for releasing with delayed effect an active substance, in particular veterinary |
| 08/25/1999 | EP0936903A1 Product with extender effect |
| 08/25/1999 | EP0936902A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy |
| 08/25/1999 | EP0936901A1 Pharmaceutical composition for rapid suspension in aqueous media |
| 08/25/1999 | EP0936897A1 Composition having tanning and sun-screening activity, and cosmetic uses thereof |
| 08/25/1999 | EP0936894A1 Closure system for an active agent delivery device |
| 08/25/1999 | EP0936893A1 Multiple flow path device for oral delivery of discrete units |
| 08/25/1999 | EP0936874A1 Chewing gums and method of manufacturing the same |